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Abstract: Glaucoma and macular degeneration are leading causes of irreversible blindness, 
significantly compromising the quality of life and having a high economic and social impact. 
Promising therapeutic approaches aimed at regenerating or bypassing the damaged anatomi-
cal-functional components are currently under development: these approaches have gener-
ated great expectations, but to be effective require a visual network that, despite the 
pathology, maintains its integrity up to the higher brain areas. In the light of this, the existing 
findings concerning how the central nervous system modifies its connections following the 
pathological damage caused by glaucoma and macular degeneration acquire great interest. 
This review aims to examine the scientific literature concerning the morphological and 
functional changes affecting the central nervous system in these pathological conditions, 
summarizing the evidence in an analytical way, discussing their possible causes and high-
lighting the potential repercussions on the current therapeutic perspectives. 
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Introduction
Rational
Among the various diseases of ophthalmological interest, those with the highest 
impact on the general population in terms of prevalence and morbidity are macular 
degeneration (in particular, senile macular degeneration) and glaucoma. 
Maculopathy and glaucoma are in fact the second and third cause of blindness in 
the world after cataract.1
Glaucoma, in particular, is the leading cause of irreversible blindness world-
wide. A recent study2 reported that 3.5% of the population, or about 64 million 
people, currently suffer from glaucoma. Of these, 5.7 million have a visual defect, 
and 3.1 million are blind. It is predicted that the number of people worldwide 
suffering from glaucoma will rise to 111.8 million by 2040.
“Macular Degeneration” is a term that includes several distinct pathological 
entities in two groups: JMD (Juvenile Macular Degeneration), characterized by 
earlier onset and AMD (Age-related Macular Degeneration), typical instead of 
older age and especially over 60. Specifically, AMD, the most frequent of the 
two, accounts for 8.7% of all blind people in the world and is the most common 
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cause of legal blindness in developed countries.3 It is 
estimated that its prevalence will increase as a result of 
the lengthening of average life expectancy, with the num-
ber of affected people in the world increasing from 
9.1 million today to 17.8 million in 2050.4 The impact 
that these pathologies have on public health is therefore 
evident, and from this remark derives the interest in 
a wider possible understanding of the phenomenon. 
There is much evidence to suggest that the alterations 
resulting from these two pathologies are not limited to 
the retina alone, but also affect the central nervous system 
in both structural and functional terms.5,6 It is our aim, 
with this review, to summarise and compare the data 
currently available in the literature concerning the modifi-
cations occurring at the CNS level, to identify their likely 
causes and to discuss the implications they may have in 
the context of existing or developing rehabilitation and 
therapeutic strategies.
Glaucoma
The term glaucoma refers to a heterogeneous group of 
pathological entities, sharing an optic neuropathy charac-
terized by the progressive degeneration of retinal ganglion 
cells and their axons, which results in optic atrophy and 
progressive loss of visual field, starting from the most 
peripheral areas up to the central vision.7 In particular, 
primary open-angle glaucoma (POAG) is the most com-
mon variant;8 other types of glaucoma are primary angle 
closure glaucoma (PACG) and normal tension glau-
coma (NTG).
Although high intraocular pressure and/or insufficient 
optic nerve perfusion pressure have been identified as the 
main agents involved in glaucomatous damage, the exact 
pathogenic mechanism is still unclear today. It is interest-
ing to point out that certain studies have shown similarities 
between the alterations existing in glaucoma and some 
primitive neurodegenerative pathologies affecting CNS 
such as Alzheimer’s Disease,9–11 in particular regarding β- 
amyloid accumulation, its neurotoxic role and the loss of 
ganglion cells, as is further discussed below. In this respect 
instrumental imaging, which is widely used in the clinical 
assessment of glaucoma, allows to evaluate some common 
features: in glaucoma Optical Coherence Tomography 
(OCT) typically detects a thickness reduction of peripapil-
lary RNFL (Retinal Nerve Fiber Layer) and macular GCC 
(Ganglion Cell Complex) as a result of ganglion cells 
degeneration: this structural analysis allows,especially 
with the assessment of GCC thickness, an early 
objectification of glaucomatous damage even in early 
stages before the onset of visual field deficit.11–13 
Likewise, in Alzheimer’s Disease (AD, the most common 
neurodegenerative cause of dementia14) OCT analysis has 
revealed a reduced thickness of GCC and RNFL, for 
which neuronal retrograde degeneration is one of the 
main plausible hypotheses taken into account.15 Even 
more interesting are the results obtained through OCT- 
angiography (OCT-A), which allows the evaluation of 
the retinal blood vessels: the retinal vascular network has 
many similarities with the cerebral vasculature, potentially 
reflecting the modifications occurring in some neurodegen-
erative diseases such as AD.9,16 In glaucoma, the existence 
of an unstable ocular perfusion has been previously 
demonstrated in the optic nerve, retina, and extraocular 
level,17 either due to IOP fluctuation or to a to primary 
vascular dysregulation, which is responsible for both 
ischemic damage and subsequent reperfusion injury to 
the ganglion cells:18 moreover, using OCT-A it was pos-
sible to observe an effective reduction of macular micro-
vascular flow, particularly in the superficial retinal 
plexus.19–21 This flow disturbance would lead to 
a reduction in the thickness of GCC and RNFL, anatomi-
cally more susceptible to this impairment, showing an 
association between visual field defect, flow reduction 
and thinning of the layer.22 Interestingly, a reduction in 
macular flow has also been observed in AD, but this time 
involving both the superficial and deep retinal 
plexus.16,23,24 It has been hypothesized this alteration 
could be produced by intraretinal deposition of β- 
amyloid, which has been identified in AD patients, causing 
both a mechanical compression on capillaries and 
a physical obstacle to the diffusion of oxygen and 
nutrients:16 this would result in a metabolic distress to 
ganglion cells and a subsequent degeneration and thinning 
of the GCC, which correlates with the disease severity.16 
To date, the main therapeutic strategy for glaucoma is 
lowering IOP through the use of hypotonic drugs or sur-
gery. This approach can be accompanied by nutritional 
supplementation for neuroprotective purposes.25 
However, many therapeutic options are currently being 
studied and developed, such as glial cell modulation, 
stem cell therapy, gene therapy.26 These approaches aim 
at restoring the correct functioning of ganglion cells and 
allowing a renewed flow of visual information to the brain: 
it must be underlined, however, that such therapeutic pro-
posals need, in order to be successful, the guarantee of an 
unaltered circuitry in the brain, which otherwise would not 
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allow the correct signal processing once the restitutio ad 
integrum of neuroretinal structures has been obtained.
Macular Degeneration
Age-related Macular Degeneration (AMD) has ageing as 
its main risk factor, and causes macular damage primarily 
to the outer retinal layers, which results in the impossibil-
ity of processing the light stimulus into a nerve signal and 
therefore the loss of the central portion of the visual 
field.27 Juvenile Macular Degeneration (JMD) is a group 
of diseases, among which Stargardt’s disease and Best 
vitelliform macular dystrophy are the main ones, with 
onset during childhood/adolescence. These diseases lead, 
similarly to AMD, to degeneration of the photoreceptors at 
the macular level, with loss of the central visual field. This 
time, however, the cause is to be found in metabolic- 
structural defects at the cellular level, on a genetic basis. 
Similar to AMD, the final stage of the pathology involves 
central neuroretinal atrophy.
Current therapies are directed in particular towards 
the neovascular form of AMD, through the use of intra-
vitreally administered anti-VEGF molecules. No defini-
tive therapies currently exist for the dry form of AMD 
and JMD. Therapeutic strategies are under 
development28–34 including pharmacological stimulation 
of neuroplasticity through Chondroitinase-ABC, macular 
surgery, prosthetic implantation, gene therapy; again, as 
with glaucoma, we are therefore faced with therapeutic 
perspectives that aim to obtain, at least in part, 
a restitutio ad integrum of the damaged retinal structure. 
In light of this, it is clear the importance that 
a modification of the network of neuronal circuits in 
charge of processing the visual signal following the 
pathological damage at retinal level may have, which 
could hinder, once the functional restoration of the retina 
has been achieved, a correct processing of the informa-
tion and frustrate the therapeutic effort.
Methods
Search Strategy
We looked for studies dealing with changes in the visual 
and/or cerebral pathway during glaucoma or maculopathy 
(AMD and JMD) evaluated using imaging techniques. This 
research was conducted on MEDLINE Daily, MEDLINE 
(Ovid), MEDLINE In-Process and Other Non-Indexed 
Citations, CENTRAL, EMBASE, Latin American and 
Caribbean Literature on Health Sciences (LILACS), 
CINAHL (EBSCO), Trip Database and The National 
Institute for Health and Care Excellence (NICE). No date 
or language restrictions have been used in the search. 
Articles published until December 2020 have been included.
Study Design
In order to produce this review, we included randomized 
controlled trials, clinical trials, non-randomized compara-
tive studies, cohort studies and case series. Case report, 
case series with less than 6 patients and articles with 
incomplete outcome data were excluded.
Participants and Interventions
We have included studies in patients with Primary Open 
Angle Glaucoma (POAG), Primary Angle Closure 
Glaucoma (PACG), Normal Tension Glaucoma (NTG), 
Age-related Macular Degeneration (AMD) and Juvenile 
Macular Degeneration (JMD). Functional damage could 
be both unilateral and bilateral. Stage of pathology was 
not considered as exclusion criteria.
We included studies using the following imaging tech-
niques for the study of brain characteristics:
- Diffusion tensor MRI (DT MRI/DTI)
- Voxel-based Morphometry (VBM)
- Surface-based Morphometry (SBM)
- Functional Magnetic Resonance Imaging (fMRI)
- Resting-state fMRI (rs-fMRI)
- Arterial spin labelling (ASL) MRI
- Magnetic resonance spectroscopy (MRS)
Patients’ characteristics are reported in Table 1.
Data Sources and Studies Selection
Research about macular degeneration has resulted in 
a total of 142 articles. After the exclusion of duplicated 
results, not relevant or not covered by inclusion criteria, 
we obtained a final number of 19 articles. For glaucoma, 
the number of articles initially identified was 1911. As 
a result of the selection process, a final number of 64 
articles was obtained.
In particular, among the studies selected for macular 
degeneration, 6 involve AMD, 6 JMD and 4 both, with 
a total of 364 patients (47.8% AMD; 52.1% JMD) and 325 
controls. Among those selected for glaucoma, 54 studies con-
cern POAG, 7 PACG and 9 NTG, for a total of 1502 patients 
(79.4% POAG; 10.4% PACG; 10.2% NTG) and 1178 
controls.
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Analysis of Morphological and Functional 
Alterations Detected in the CNS During 
Glaucoma (POAG, PACG, NTG)
The structure of the white matter has been studied using 
indirect (DTI) and direct (VBM) methods. These studies 
have shown the presence of structural microalterations 
along the entire visual pathway, involving the optic 
nerve,35–40 optic tract,41–46 optic radiation35,36,41–59 up to 
visual areas BA17, BA18 and BA19 at occipital lobe 
level60–62 [Figure 1]. These findings are based on the 
analysis of fractional anisotropy (FA), i.e. 
a quantification of the directionality of water diffusion 
within a voxel, which was found to be lower than normal; 
a change in the value of FA, in particular a reduction in it, 
is an indirect sign of microstructural damage in the white 
matter. Other variables considered were the increase in 
Table 1 Demographic and Clinical Characteristics
N. Patients Mean Age (in Yrs.)
AMD JMD CONTROLS AMD JMD CONTROLS
174 190 325 74.1° 39.3° 47.6°°
POAG NTG PACG CONTROLS POAG NTG PACG CONTROLS
1192 156 154 1178 54* 53.9** 49.9*** 50.3****
Notes: °Value subject to approximation - out of a total of studies 26 did not provide the average age but only the range; 1 did not provide data about age. Two studies 
shared the same patients; °°Value subject to approximation - out of a total of 19 studies 2 did not provide the average age but only the range; 1 did not provide data about 
age; *Value subject to approximation - out of a total of 45 studies 2 gave the average age of a group consisting of POAG and NTG without distinction between the two 
subgroups; 2 gave the average age of a group consisting of POAG and PACG without distinction between the two subgroups; 1 did not give the average age but only the 
range; **Value subject to approximation - out of a total of 8 studies, 2 gave the average age of a group consisting of POAG and NTG without distinction between the two 
subgroups; 1 did not give the average age but only the range; ***Value subject to approximation - out of a total of 7 studies 2 gave the average age of a group consisting of 
POAG and PACG without distinction between the two subgroups; ****Value subject to approximation - out of a total of 52 studies 1 did not provide the average age but 
only the range; 3 did not provide a given age.
Figure 1 (A) Brodmann area 17, lateral and medial view. (B) Brodmann area 18, lateral and medial view. (C) Brodmann area 19, lateral and medial view.  
Notes: Adapted from: Brodmann K. Vergleichende Lokalisationslehre der Grosshirnrinde in ihren Prinzipien dargestellt auf Grund des Zellenbaues [Comparative 
localization theory of the cerebral cortex presented in its principles on the basis of the cell structure]. Leipzig: Johann Ambrosius Barth Verlag; 1909. German.129
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mean diffusivity (MD) and radial diffusivity (RD), also 
a sign of axonal damage. We cannot consider these obser-
vations as a reduction of white matter in the strict sense, 
but certainly as alteration and damage of the structures 
belonging to it. Even more interesting was the detection of 
alterations involving numerous brain areas outside the 
proper visual pathway. Abnormal values of FA and MD 
in DTI-MRI technique, therefore index of axonal damage, 
were detected in corpus callosum, hippocampus, parietal 
lobes, supramarginal gyrus, upper longitudinal fasciculus, 
rostrolateral prefrontal cortex and lower frontal 
gyrus43,46,62,63 in all types of glaucoma (POAG; PACG; 
NTG); these brain structures are linked to superior visual 
and cognitive functions. Furthermore, an altered signal 
was detected in the fronto-occipital fasciculus (visual- 
spatial function), longitudinal fasciculus, inferior-frontal 
fasciculus (visual memory), putamen, caudate nucleus 
and internal capsule (interaction between vision and move-
ment, orientation).64 These alterations have shown direct 
correlation with disease progression: in particular, FA 
parameter is negatively correlated with the severity of 
glaucomatous disease in terms of RNFL, visual field and 
cup-to-disc ratio alterations; MD and RD are instead posi-
tively correlated.35,37–41,45,52,54,58 The cause of these 
modifications seems to be a form of transsynaptic neuro-
degeneration extending in an anterograde and retrograde 
sense along the structures involved in visual function, 
starting from the ganglion cells to the upper brain areas 
with associative function.49,65 Of great interest is the result 
reported by Boucard,63 who reported microstructural 
alterations (in terms of reduced FA in DTI) in the corpus 
callosum in a group of patients with normotensive glau-
coma. This observation, in a brain structure so extraneous 
to visual function, may suggest a pathogenic component 
that can no longer be explained by anterograde and/or 
retrograde neuronal degeneration alone, but rather as an 
additional and independent mechanism of neurodegenera-
tion acting in glaucoma, with features partly reminiscent 
of Alzheimer’s disease.66 Microstructural alterations 
appear associated with a loss of density and volume of 
white matter. Direct measurement of white matter was 
performed using the Voxel-Based Morphometry (VBM) 
technique, identifying a volumetric reduction along the 
entire pathway (optic nerves, chiasma, optic traits, CGL, 
optic radiation).50 Again, these alterations, particularly in 
optic radiation, were directly correlated with both severity 
of optic nerve damage (optic atrophy) and loss of visual 
field.
Figure 2 Calcarine fissure (in red), medial view. Gray H. Anatomy of the Human Body. Philadelphia: Lea & Febiger; 1918.130
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Grey matter has also been subject of attention. Many 
studies, through the use of VBM, have reported a significant 
reduction in volume and density of grey matter within the 
primary visual cortex.42,43,46,50,59,64,67–71 It should be noted 
that this reduction was significant only in the most anterior 
part of the calcarine fissure, reinforcing the idea of retino-
topically distributed damage72 [Figure 2]. This data 
acquires even more significance if compared with MD 
(see below), where the reduction in volume is concentrated 
in the posterior part, where the projections coming from the 
central area of the retina are located. A volumetric reduction 
was also detected outside the visual cortex, at lingual gyrus, 
postcentral gyrus, superior frontal gyrus, inferior frontal 
gyrus, rolandic operculum, cerebellar cortex, hippocampus 
and mean temporal circumvolution.42,67,68,73 Again, the 
involvement of such structures can be explained consider-
ing the existing connections between them and the visual 
area for the performance of higher functions related to 
vision (writing, movement and coordination, memory, 
face recognition). These alterations, as well as for white 
matter, are explained by a mechanism of transsynaptic 
diffusion of cell death signals triggered by the degeneration 
of ganglion cells both in an anterograde sense74 and, espe-
cially for areas not directly involved in the visual pathway, 
in a retrograde.63,75 Again, the positive correlation between 
the extent of brain alteration and the severity of glaucoma-
tous damage has been demonstrated.67,70,71,73 Particularly 
suggestive were the alterations found in areas such as 
Figure 3 (A) Brodmann area 7, lateral and medial view. (B) Brodmann area 46, lateral and medial view. Brodmann K. Vergleichende Lokalisationslehre der Grosshirnrinde in 
ihren Prinzipien dargestellt auf Grund des Zellenbaues [Comparative localization theory of the cerebral cortex presented in its principles on the basis of the cell structure]. 
Leipzig: Johann Ambrosius Barth Verlag; 1909. German.129
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amygdala, hippocampus, orbitofrontal cortex and superior 
parietal lobule which, although not directly related to the 
elaboration of visual informations, are involved in other 
neurodegenerative disorders such as Alzheimer’s disease, 
suggesting again similarities between the two pathological 
conditions.42,71
Even so, not all the studied areas showed volumetric 
reduction; on the contrary in some of them the volume was 
increased: this is the case of midbrain, left brainstem, 
frontal gyrus, cerebellar vermis, left inferior parietal 
lobule, caudate nucleus, thalamus, precuneus, and 
Brodmann areas 7, 18, and 46 [Figures 3A and B and 
1B]. As an explanation for this finding, it has been sug-
gested that it may be a consequence of neuronal damage 
(which, by causing cell swelling and microglia activation, 
may lead to an increase in volume) or a form of neuro-
plasticity linked to a greater functional activation and 
consequent increase in dendritic arborisation. This altera-
tion in volume, however, has not always been associated 
with a functional modification: this latter data makes us 
more inclined towards the first etiological hypothesis.59 
Alongside these various morphological alterations there 
were also modifications in brain activity: through the use 
of fMRI a reduction in the activation of the primary visual 
cortex following visual stimulation has been identified in 
POAG,48,55,59,76–81 NTG48,78,81 and PACG.82 Using rs- 
fMRI, and measuring cerebral blood flow by arterial spin 
labeling MRI,83,84 a reduction in neuronal activity was 
also observed in resting state in visual cortex, motor cor-
tex, somatosensory cortex and Default Mode Network 
(DMN, a major neuronal network comprising prefrontal 
cortex, medial temporal lobe, inferior parietal lobe, poster-
ior cingulate cortex, angular gyrus and hippocampus, that 
deactivates during goal-directed tasks). Neuronal connec-
tivity in resting-state61,84–86 was also found to be 
decreased bilaterally, both in areas directly related to the 
visual process (primary visual cortex and superior visual 
areas) and indirectly, such as between visual cortex and 
R superior/inferior temporal gyrus, R/L fusiform gyrus, 
L inferior frontal gyrus, L middle occipital gyrus, 
R angular gyrus, R superior occipital gyrus, L postcentral 
gyrus, R precentral gyrus, anterior lobe of the left cerebel-
lum. On the contrary, increased connectivity was present 
towards L cerebellum, R middle cerebellar peduncle, 
R middle frontal gyrus and extra-nuclear gyrus. This 
reduction in functional connectivity appears to correlate 
with visual field deficit and glaucoma stage,84 although 
a demonstrated cause-effect relationship is lacking to 
date;85 the reduced connectivity involving visual areas 
has also been related with thickness reduction of retinal 
RNFL.61 The reason for all these modifications is not 
clear; it has been suggested that the reduced functional 
activity and connectivity may be secondary to transsynap-
tic degeneration and/or decreased visual information 
flow.43,87 The increase in connectivity, often coexisting 
with an increased volume involving associative 
areas59,67–69 is probably secondary to the reduction in 
GABAergic inhibitory signalling which, through visual 
feedback, visual areas normally exert on some higher 
areas.88 In summary, in glaucomatous patients neuronal 
connectivity was found to be reduced in the context of 
the areas inside the visual cortex and between the visual 
cortex and the designated areas for visual memory, work-
ing memory, attention and motor coordination; it was 
instead found to be increased between the visual cortex 
and the areas designated for cognitive association and 
limbic system:65,75 it is suggestive to associate these mor-
pho-functional modifications with some cognitive- 
behavioural alterations described in patients affected by 
glaucoma: the first observation can be associated with 
impairment of memory, coordination and posture, 
the second with the greater prevalence of anxiety and 
depression demonstrated in subjects suffering from 
glaucoma.89,90 The modified functional connectivity invol-
ving the amygdala has also been related to the emotional 
impairment that is sometimes described in glaucomatous 
subjects.86 Also noteworthy is the altered functional con-
nectivity between the visual network and the default mode 
network, involved in attention and executive function, 
whose nodal point (the posterior cingulate cortex) has 
demonstrated a close correlation with disease progression 
in Alzheimer’s.85 The same network also demonstrated 
a reduced neuronal activity at rest, again 
resembling AD.87 More recent studies have also 
identified60 a reduction in connectivity from the BA17 
primary visual area to the BA18 and BA19 superior visual 
areas, and vice versa a greater connectivity from the super-
ior ones to the primary; increased connectivity was also 
found between the primary visual area and extrastriated 
associative areas such as fusiform gyrus (shape, face, 
colour recognition), precuneus gyrus, posterior cingulate 
cortex (visual memory, visuospatial attention) and soma-
tosensory cortex: there is so a situation of reorganization 
within the visual cortex and between the visual cortex and 
the associative areas, with a flow of information that is 
overall reduced in a hierarchically ascending sense (from 
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the primary visual area to the superior visual areas to the 
associative areas) and vice versa increased in a descending 
sense. The meaning of these observations remains uncer-
tain, it is probable that could be a reorganization aimed at 
compensating the glaucomatous damage that involves 
a deficit of information coming from the retina to the 
visual cortex; the same thing has been hypothesized to 
explain the increased resting activity of prefrontal cortex, 
L superior temporal gyrus, L inferior parietal lobule, 
R middle cingulate cortex.87 These modifications are 
once again associated with some features found in glauco-
matous patients, such as trouble in visuomotor coordina-
tion and somatosensory impairment. Similarly, a reduced 
connectivity between visual cortex, supramarginal gyrus 
(involved in oculomotor control), superior sensorimotor 
areas and cerebellum seems to be reflected in a difficult 
postural control and an increased risk of falling.91,92
Analysis of Morphological and Functional 
Alterations Detected in the CNS During 
Macular Degeneration (AMD, JMD)
Structural alterations were detected in both grey and white 
matter. The white matter was volumetrically reduced along 
the entire visual pathway, although with some differences 
between JMD and AMD: in the first case all structures 
were involved (optic nerve, chiasm, lateral geniculate 
bodies, optic radiations and visual cortex), while in 
the second case only those downstream of the lateral 
geniculate bodies (lateral geniculate bodies, optic radia-
tions and visual cortex). The volumetric reduction 
observed in patients with JMD also appeared to be quanti-
tatively greater: this data in particular would seem to be 
linked to the greater primitive alteration existing in JMD 
compared to AMD, consequent to an anatomo-functional 
retinal damage on average wider, and therefore with 
greater visual field involvement.93 Another difference 
was the involvement, once again in terms of volumetric 
reduction, of the frontal lobe white matter in AMD 
patients only; this observation was explained as a result 
of a coexisting non-specific senile degeneration in patients 
who, compared to the JMD group, are on average older. 
With regard to grey matter, its reduction has been recorded 
at the level of the occipital pole93–96 in correspondence 
with the calcarine fissure, particularly in its posterior 
part.94 This last detail is consistent with what discussed 
for glaucoma, where the anterior part is mainly involved, 
and supports the hypothesis of a damage distributed to the 
visual cortex with a retinotopic pattern, which in turn 
corresponds to the visual field deficit. These volumetric 
alterations are negatively correlated with the severity of 
visual field deficit and with the patient’s reading speed.95 
On the contrary, Olivo96 demonstrated in patients with 
JMD (and in particular Stargardt’s disease) an increase in 
grey matter in the left supramarginal gyrus.
The reduction in the volume of grey and white matter 
has been explained as a consequence of a trans-synaptic 
degeneration related to central retinal damage, and distrib-
uted in a retinotopic way at a cerebral level.6 The increase 
in grey matter observed by Olivo is likely to have 
a compensatory meaning, since this area is involved in 
eye movement, and particularly in the adaptation of hand- 
eye coordination.
As far as functional alterations are concerned, all stu-
dies in the literature have found a reduced activation of the 
visual cortex in subjects suffering from macular degenera-
tion, both AMD and JMD.97–99 This result was accompa-
nied by some secondary findings: some areas outside the 
visual field (frontal and supplementary eye fields, prefron-
tal cortex, intraparietal sulci, parietal lobule) showed 
increased activity following visual stimulation compared 
to healthy subjects. This observation was related to the 
use, common in subjects with central visual field deficit, of 
a PRL (Preferred Retinal Locus), i.e. a retinal locus other 
than fovea, outside the degenerated area, used as a new 
point of focus of the image through an eccentric fixation. 
This method, which allows a discreet visual function to be 
achieved despite the macular pathology, requires however 
more advanced image processing and oculomotor coordi-
nation, and this effort justifies the activation of associative 
areas involved in ocular coordination such as those indi-
cated above. In addition, subjects with stable PRL showed 
greater activation of the visual area (although less than 
healthy subjects) than subjects unable to use eccentric 
fixation.100–104 Not only that, but the use of a PRL led to 
an activation of the cortical area normally reserved to the 
projection of the fovea in V1;101,105,106 this eventuality, 
sometimes recorded with discordant results in the studies 
available in literature, was observed especially during 
stimulus-related tasks, while it tended to be absent in 
case of passive viewing. To explain this, it has been 
hypothesized a remodelling of neural pathways thanks to 
a mechanism of neuronal plasticity, or an activation of 
task-dependent cortical connections normally inactivated 
by signals coming from the retina. In addition, it has been 
demonstrated107 that the visual exercise, which allows the 
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achievement of greater visual performance through the 
stabilization of the eccentric fixation, involves an increase 
in cortical response to retinal stimulation, particularly in 
the area of projection of the PRL. A countertendency 
result regarding functional connectivity was reported by 
Haak108 which, in patients with Stargardt’s disease, 
showed that the existing corticocortical connections 
between V1 and V2/V3 still retained their retinotopic 
characteristics almost intact, without substantial changes.
Discussion
The high social and economic impact of diseases with 
serious visual field deficits such as glaucoma and macular 
degeneration, and the inability to restore the retina once 
the damage has been established, have led to the use of 
rehabilitation therapy alongside medical therapy, for 
example through the use of computer-based vision training 
to maximise the sensitivity of residual vision areas,109 or 
a preferred paracentral retinal locus to be used as a new 
fixation point.110,111 These methods certainly benefit from 
a morpho-functional reorganization of brain circuits at the 
head of the visual processing, which can thus compensate 
for the damage consequent to the pathology; to date, the 
occurrence of such an eventuality, based on neuronal plas-
ticity mechanisms and on the activation of normally silent 
secondary connections, seems to be plausible even if the 
evidence is not yet definitive.5,6 However, it should be 
pointed out that other therapeutic perspectives, which 
may be available in the near future, such as retinal gang-
lion cell transplantation,112 retinal prostheses,113,114 stem 
cell therapy115 and genetic therapy116 need instead the 
guarantee of an unaltered connectivity between retina 
and the brain which, if not maintained, could even result 
in a failure not allowing, once the retinal integrity is 
restored, the correct processing of the visual signal. It is 
therefore needed to summarise the current evidence 
regarding the morphological and functional alterations 
affecting the CNS in patients suffering from glaucoma 
and macular degeneration, and to compare the distribution 
of these alterations in the two pathologies deriving so the 
implications they could have on current rehabilitation 
techniques and future therapeutic possibilities.
The cerebral occipital pole is transversally involved in 
both glaucoma and maculopathy: a reduction in volume 
and density in the primary and superior visual areas has 
been recorded in both white and grey matter. The V1 area 
is involved in a retinotopic way (anterior in glaucoma, 
posterior in MD). The retinotopic visual pathway is also 
involved: in all its structures in glaucoma and JMD; down-
stream of the lateral geniculated bodies in AMD. This 
volumetric reduction is accompanied by structural micro-
alterations, affecting in particular the white matter, which 
can be explained primarily as a result of anterograde and 
retrograde transsynaptic degeneration, to be referred to the 
retinal damage and the consequent functional deprivation. 
However, a clear difference can be observed in the com-
parison between MD and glaucoma: the structural altera-
tion in the first case is almost exclusively limited to the 
visual pathway and the visual brain areas (although with 
the exception of some observations93,96 involving areas 
external to the occipital lobe, but with a probable senile 
meaning or consequent to the rehabilitation training); in 
glaucoma, on the other hand, in addition to the occipital 
lobe many other areas, even distant from each other, are 
involved along the entire brain, affecting both white and 
grey matter with a severity directly proportional to the 
extent of glaucoma damage. For many of these structures 
it is possible to explain their involvement as they are 
implicated in the integration of visual function with higher 
functions, such as movement, memory, orientation, emo-
tions, writing; other ones, however, are so unrelated to 
visual function that the co-presence of a parallel and 
separate neurodegenerative mechanism alongside the 
transsynaptic glaucoma-related degeneration is suspected, 
probably similar to the one that occur in other neurode-
generative diseases such as Alzheimer’s.63 Morphological 
alterations are accompanied by functional alterations, also 
involving the brain to varying degrees between MD and 
glaucoma. Again, in macular degeneration has been 
recorded a decreased response involving only the visual 
cortex (with the exception of a few external areas, related 
to rehabilitation training and in particular to the effort due 
to the use of a PRL as an eccentric fixation locus). 
Functional alteration in glaucoma, on the other hand, has 
been shown to be widespread and extended to the entire 
brain, and in particular to areas related to memory, atten-
tion, orientation, coordination, object and face recognition. 
In these areas, brain activity was both reduced and 
increased, probably due to a transsynaptic degeneration 
consequent to the pathological damage, and on the other 
hand due to the reduced inhibition that visual areas nor-
mally exert on these associative areas through feedback.
What explanations can be given for this discrepancy in 
observations? First of all, it needs to be considered the different 
natural history of the two pathologies, which involve different 
areas of the retina. While glaucoma produces extensive retinal 
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damage, primarily directed towards ganglion cells, involving 
first peripheral visual field and then, only in the advanced 
stages, the central field, macular degeneration causes photo-
receptor damage limited to the central part of the retina, i.e. the 
macula, which corresponds to the ten-fifteen central degrees of 
the visual field. This neuroretinal degeneration is reflected in 
a different involvement of the nerve fibres starting from the 
retina towards the CNS (constituting the visual pathway 
formed by optic nerve, chiasma, optic tract, CGL and optic 
radiation), thus leading to a morpho-functional alteration quan-
titatively and qualitatively different at cerebral level, with 
a retinotopic distribution of the damage in the visual cortex.
Why so many areas outside the visual one are involved 
in glaucoma is still unclear. In the vast majority of cases 
these areas are actually related to visual function, but do not 
appear to be altered in course of macular degeneration: we 
can hypothesize that these superior functions (visuo-motor, 
visuo-mnemonic, recognition, orientation) use information 
coming mostly from the peripheral visual field, and they are 
therefore involved only during diseases affecting particu-
larly the external part of the visual field; however, this 
hypothesis is not currently supported by evidence in litera-
ture. The distribution of functional alterations would seem 
to reflect that of morphological alterations. While the visual 
cortex is involved in both pathologies, and always with 
a decreased activity, in glaucoma there is involvement of 
several external areas, widespread throughout the brain, 
with a reduced or increased functional response. This last 
observation in particular has been related to the probable 
decrease of inhibitory feedback normally coming from the 
visual areas and directed to higher associative areas in 
response to the retinal stimulus. A link has been suggested 
between this altered brain activity and some impairment 
typically observed in glaucomatous patients, particularly in 
object identification, visuospatial function, visuomotor 
coordination and somatosensory functions. Such wide-
spread brain involvement, even in areas not related to visual 
function, has also led to the hypothesis that there could be 
an additional neurodegenerative mechanism, not directly 
related to transsynaptic degeneration but, rather, more simi-
lar to what occurs in neurodegenerative diseases such as 
Alzheimer’s. It should be noted that the existence of 
a possible correlation between Alzheimer’s Disease and 
glaucoma has already been investigated previously, without 
however reaching definitive results. The hypothesis of 
a possible link between the two diseases arose from the 
observation of some shared characteristics: both diseases 
are age-related;117,118 they present progressive 
neurodegeneration;118,119 the deposits of tau protein and β- 
amyloid (major pathological features of AD, accumulating 
in the brain) have been detected in the retina of both AD 
subjects and glaucoma subjects;118,119 APOE polymorph-
isms, strongly associated with AD, have also been sus-
pected to be involved in optic nerve damage and visual 
field defect in glaucoma, although the latter is a point still 
under discussion.118 The most recent systematic reviews 
and meta-analyses117,120) conducted on the studies in litera-
ture, however, did not allow to reach a conclusive result, as 
many questions emerged: although a first analysis found 
a statistically significant increase of the risk of 
developing AD in glaucomatous patients, the results of the 
analysed studies appeared to be often contradictory and the 
studies were sometimes inadequately designed and poorly 
conducted.120 The high heterogeneity of study design and 
study population was suspected to be a source of bias so 
that, after stratifying by study type, the association 
between AD and glaucoma persisted only in the subgroup 
of case-control studies (more susceptible to selection bias 
and recall bias) while it disappeared in cohort studies.117 
Even the great genetic heterogeneity of the two diseases 
under investigation (65 genes suspected to be involved in 
glaucoma, 31 in AD117) has been accused of being a source 
of bias if not adequately controlled; the same applies to 
other potential confounders (comorbidities, alcohol drink-
ing, smoking), which were not always adequately controlled 
in the considered studies, and to the different diagnostic 
criteria used to define the diseases. The results of these 
systematic reviews, therefore, have been described as 
“hypothesis generating” and should be interpreted with 
caution.117 The association between Pseudoexfoliation 
Syndrome (PEX) and glaucoma has also been investigated 
because of some common features between the two dis-
eases: the fibrillar extracellular material typical of PEX has 
been detected not only in the eye, but also in blood vessels, 
skin, kidneys, lungs, heart, and meninges;121 moreover, 
polymorphisms of the LOXL1 gene,122 as well as of the 
APOE gene,123 were initially associated with both PEX 
and AD, although this association was later 
disproved.124,125 In addition, β-amyloid peptide has been 
demonstrated in aqueous humour of PEX patients.122 
Despite these clues, after a first possible evidence of asso-
ciation between PEX and AD,126,127 subsequent population- 
based studies (the major limitation of the previous studies 
was the hospital-based design with consequent possible 
selection bias) have rejected this correlation and excluded 
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the hypothesis that PEX may be a risk factor for 
Alzheimer’s Disease.122,128
Whether at least some of these morpho-functional altera-
tions could be a sign not only of degeneration but also of 
occurred remodelling based on neuroplasticity is still under 
discussion. In the context of these pathologies, the evidence of 
remodelling has already been suggested,5,6 but to date there is 
no definitive evidence that these changes may reflect a real 
plasticity of the adult CNS following the pathological insult, 
rather than a simpler adaptation through the activation of 
normally silent collateral and secondary circuits. Obtaining 
definitive evidence in this area would have great repercussions 
in a therapeutic perspective: as discussed above, if 
a remodelling would certainly be useful within 
a rehabilitation path aimed at maximising the residual visual 
capacity and compensating for the lost one, a modification of 
the nervous circuits between retina and the brain, and between 
the different brain areas, could on the contrary compromise the 
potential results of therapeutic approaches still in development 
(cell therapy, gene therapy, transplantation and retinal prosthe-
sis) which, in order to restore the functioning of the damaged 
retina, would require an intact downstream neuronal circuitry 
for the correct processing of the visual signal.
Conclusions
The data in literature to date show that both in glaucoma and 
macular degeneration the CNS is affected by morphological 
and functional alterations. These alterations are limited to 
visual areas in MD, while involve multiple brain areas in 
glaucoma. The causes and mechanisms at the base of these 
modifications are not yet clear: the main hypotheses are 
ascribable to a mechanism of transsynaptic degeneration 
linked to functional deprivation following retinal damage; 
to the activation of normally silent collateral circuits; to 
involutionary mechanisms similar to those proper to primi-
tive neurodegenerative pathologies such as Alzheimer’s dis-
ease and to remodelling through neuronal plasticity but, in 
particular with regard to the last two points, evidence are not 
yet definitive. If it is legitimate to suppose that these mod-
ifications, which have been shown to have (at least partially) 
adaptive meaning, could favour a rehabilitation path com-
pensating for the damage consequent to the pathology, it is 
also true that they could hinder the therapeutic strategies 
currently under development with the aim of restoring the 
damaged neuroretina: if these modifications were not rever-
sible, the change in the neural networks at the basis of the 
connection existing between the retina and the brain, and 
between the different areas of the brain, would hinder the 
correct processing of the visual signal. This problem could 
occur mainly in glaucoma, which shows a widespread invol-
vement in a large part of the CNS, rather than in MD where 
the modifications are more isolated at the posterior pole. It is 
therefore necessary to obtain more evidence both regarding 
an improved characterisation of the alterations existing in 
these patients (the results found in current literature were not 
always of unequivocal interpretation, due to the heterogene-
ity of patients’ characteristics, stage of illness, used stimuli, 
type of analysis carried out and studied brain areas) and to 
investigate whether these changes could be reversible or not.
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